On the Origins of Diffusion MRI Signal Changes in Stroke.

Magnetic resonance imaging (MRI) is a leading diagnostic technique especially for neurological studies. However, the physical origin of the hyperintense signal seen in MR images of stroke immediately after ischemic onset in the brain has been a matter of debate since it was first demonstrated in 1990. In this article, we hypothesize and provide evidence that changes in the glial cells, comprising roughly one-half of the brain's cells and therefore a significant share of its volume, accompanying ischemia, are the root cause of the MRI signal change.

Reversible diffusion-weighted imaging lesions in acute ischemic stroke: A systematic review.

Objectives: To systematically review the literature for reversible diffusion-weighted imaging (DWIR) lesions and to describe its prevalence, predictors, and clinical significance.

Methods: Studies were included if the first DWI MRI was performed within 24 hours of stroke onset and follow-up DWI or fluid-attenuated inversion recovery (FLAIR)/T2 was performed within 7 or 90 days, respectively, to measure DWIR. We abstracted clinical, imaging, and outcomes data.

A geometric framework for ensemble average propagator reconstruction from diffusion MRI.

Diffusion-weighted magnetic resonance imaging (dMRI) is a non-invasive technique to probe the complex micro-architecture of the tissue being imaged. The diffusional properties of the tissue at the imaged resolution are well captured by the ensemble average propagator (EAP), which is a probability density function characterizing the probability of water molecule diffusion. Many properties in the form of imaging 'stains' can then be computed from the EAP that can serve as bio-markers for a variety of diseases.

TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis.

Rationale: The TIME trial (Timing in Myocardial Infarction Evaluation) was the first cell therapy trial sufficiently powered to determine if timing of cell delivery after ST-segment-elevation myocardial infarction affects recovery of left ventricular (LV) function.

Objective: To report the 2-year clinical and cardiac magnetic resonance imaging results and their modification by microvascular obstruction.

Methods And Results: TIME was a randomized, double-blind, placebo-controlled trial comparing 150 million bone marrow mononuclear cells versus placebo in 120 patients with anterior ST-segment-elevation myocardial infarctions resulting in LV dysfunction.

Ventricular Fibrillation-Induced Cardiac Arrest Results in Regional Cardiac Injury Preferentially in Left Anterior Descending Coronary Artery Territory in Piglet Model.

. Decreased cardiac function after resuscitation from cardiac arrest (CA) results from global ischemia of the myocardium. In the evolution of postarrest myocardial dysfunction, preferential involvement of any coronary arterial territory is not known.

Tractography from HARDI using an intrinsic unscented Kalman filter.

A novel adaptation of the unscented Kalman filter (UKF) was recently introduced in literature for simultaneous multitensor estimation and fiber tractography from diffusion MRI. This technique has the advantage over other tractography methods in terms of computational efficiency, due to the fact that the UKF simultaneously estimates the diffusion tensors and propagates the most consistent direction to track along. This UKF and its variants reported later in literature however are not intrinsic to the space of diffusion tensors.

Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.

Context: While the delivery of cell therapy after ST-segment elevation myocardial infarction (STEMI) has been evaluated in previous clinical trials, the influence of the timing of cell delivery on the effect on left ventricular function has not been analyzed.

Objectives: To determine the effect of intracoronary autologous bone marrow mononuclear cell (BMC) delivery after STEMI on recovery of global and regional left ventricular function and whether timing of BMC delivery (3 days vs 7 days after reperfusion) influences this effect.

Design, Setting, And Patients: A randomized, 2 × 2 factorial, double-blind, placebo-controlled trial, Timing In Myocardial infarction Evaluation (TIME) enrolled 120 patients with left ventricular dysfunction (left ventricular ejection fraction [LVEF] ≤ 45%) after successful primary percutaneous coronary intervention (PCI) of anterior STEMI between July 17, 2008, and November 15, 2011, as part of the Cardiovascular Cell Therapy Research Network sponsored by the National Heart, Lung, and Blood Institute.

Electromechanical and structural alterations in the aging rabbit heart and aorta.

Aging increases the risk for arrhythmias and sudden cardiac death (SCD). We aimed at elucidating aging-related electrical, functional, and structural changes in the heart and vasculature that account for this heightened arrhythmogenic risk. Young (5-9 mo) and old (3.

Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.

Context: Clinical trial results suggest that intracoronary delivery of autologous bone marrow mononuclear cells (BMCs) may improve left ventricular (LV) function when administered within the first week following myocardial infarction (MI). However, because a substantial number of patients may not present for early cell delivery, the efficacy of autologous BMC delivery 2 to 3 weeks post-MI warrants investigation.

Objective: To determine if intracoronary delivery of autologous BMCs improves global and regional LV function when delivered 2 to 3 weeks following first MI.

High field magnetic resonance microscopy of the human hippocampus in Alzheimer's disease: quantitative imaging and correlation with iron.

We report R(2) and R(2) in human hippocampus from five unfixed post-mortem Alzheimer's disease (AD) and three age-matched control cases. Formalin-fixed tissues from opposing hemispheres in a matched AD and control were included for comparison. Imaging was performed in a 600MHz (14T) vertical bore magnet at MR microscopy resolution to obtain R(2) and R(2) (62 μm×62 μm in-plane, 80 μm slice thickness), and R(1) at 250 μm isotropic resolution.

Quantification of myocardial segmental function in acute and chronic ischemic heart disease and implications for cardiovascular cell therapy trials: a review from the NHLBI-Cardiovascular Cell Therapy Research Network.

Global left ventricular (LV) ejection fraction (LVEF) has been used as a measure of improvement in LV function following cell therapy. Although the impact of cell therapy on LVEF in short- and long-term follow-up has been generally positive, there is concern that research evaluating regional therapeutics (e.g.

ATLAS CONSTRUCTION FROM HIGH ANGULAR RESOLUTION DIFFUSION IMAGING DATA REPRESENTED BY GAUSSIAN MIXTURE FIELDS.

Groupwise image registration is an essential part of atlas construction which is a very import and challenging task in medical image analysis. In this paper, we present a novel atlas construction technique using a groupwise registration of high angular resolution diffusion (MR) imaging datasets each of which is represented by a Gaussian Mixture field. To solve the registration problem, an L(2) distance is used to measure the similarity between two Gaussian Mixtures, which leads to an energy function whose gradient can be computed in closed form.

LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction.

A realistic goal for cardiac cell therapy may be to attenuate left ventricular remodeling following acute myocardial infarction to prevent the development of congestive heart failure. Initial clinical trials of cell therapy have delivered cells 1 to 7 days after acute myocardial infarction. However, many patients at risk of developing congestive heart failure may not be ready for cell delivery at that time-point because of clinical instability or hospitalization at facilities without access to cell therapy.

Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and design.

Background: The increasing worldwide prevalence of coronary artery disease (CAD) continues to challenge the medical community. Management options include medical and revascularization therapy. Despite advances in these methods, CAD is a leading cause of recurrent ischemia and heart failure, posing significant morbidity and mortality risks along with increasing health costs in a large patient population worldwide.

Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction.

Several previous studies have demonstrated that administration of autologous bone marrow-derived mononuclear cells (BMMNCs) improves cardiac function in patients after acute myocardial infarction (AMI). However, optimum timing of administration has not been investigated in a clinical trial. The Cardiovascular Cell Therapy Research Network was developed and funded by the National Heart, Lung, and Blood Institute to address important questions such as timing of cell delivery and to accelerate research in the use of cell-based therapies.

Labeling of stem cells with monocrystalline iron oxide for tracking and localization by magnetic resonance imaging.

Precise localization of exogenously delivered stem cells is critical to our understanding of their reparative response. Our current inability to determine the exact location of small numbers of cells may hinder optimal development of these cells for clinical use. We describe a method using magnetic resonance imaging to track and localize small numbers of stem cells following transplantation.

Regularized positive-definite fourth order tensor field estimation from DW-MRI.

In Diffusion Weighted Magnetic Resonance Image (DW-MRI) processing, a 2nd order tensor has been commonly used to approximate the diffusivity function at each lattice point of the DW-MRI data. From this tensor approximation, one can compute useful scalar quantities (e.g.

Extracting tractosemas from a displacement probability field for tractography in DW-MRI.

In this paper we present a novel method for estimating a field of asymmetric spherical functions, dubbed tractosemas, given the intra-voxel displacement probability information. The peaks of tractosemas correspond to directions of distinct fibers, which can have either symmetric or asymmetric local fiber structure. This is in contrast to the existing methods that estimate fiber orientation distributions which are naturally symmetric and therefore cannot model asymmetries such as splaying fibers.

FAST DISPLACEMENT PROBABILITY PROFILE APPROXIMATION FROM HARDI USING 4TH-ORDER TENSORS.

Cartesian tensor basis have been widely used to approximate spherical functions. In Medical Imaging, tensors of various orders have been used to model the diffusivity function in Diffusion-weighted MRI data sets. However, it is known that the peaks of the diffusivity do not correspond to orientations of the underlying fibers and hence the displacement probability profiles should be employed instead.

Registration of high angular resolution diffusion MRI images using 4th order tensors.

Registration of Diffusion Weighted (DW)-MRI datasets has been commonly achieved to date in literature by using either scalar or 2nd-order tensorial information. However, scalar or 2nd-order tensors fail to capture complex local tissue structures, such as fiber crossings, and therefore, datasets containing fiber-crossings cannot be registered accurately by using these techniques. In this paper we present a novel method for non-rigidly registering DW-MRI datasets that are represented by a field of 4th-order tensors.

Tensor splines for interpolation and approximation of DT-MRI with applications to segmentation of isolated rat hippocampi.

In this paper, we present novel algorithms for statistically robust interpolation and approximation of diffusion tensors-which are symmetric positive definite (SPD) matrices-and use them in developing a significant extension to an existing probabilistic algorithm for scalar field segmentation, in order to segment diffusion tensor magnetic resonance imaging (DT-MRI) datasets. Using the Riemannian metric on the space of SPD matrices, we present a novel and robust higher order (cubic) continuous tensor product of B-splines algorithm to approximate the SPD diffusion tensor fields. The resulting approximations are appropriately dubbed tensor splines.

Robust Tensor Splines for Approximation of Diffusion Tensor MRI Data.

In this paper, we present a novel and robust spline approximation algorithm given a noisy symmetric positive definite (SPD) tensor field. Such tensor fields commonly arise in the field of Medical Imaging in the form of Diffusion Tensor (DT) MRI data sets. We develop a statistically robust algorithm for constructing a tensor product of B-splines - for approximating and interpolating these data - using the Riemannian metric of the manifold of SPD tensors.

Drug eluting coronary stent: in vitro evaluation of magnet resonance safety at 3 Tesla.

Purpose: To evaluate MR safety at 3 Tesla for a drug eluting coronary stent.

Methods: A drug eluting coronary stent (Endeavor, cobalt alloy, Medtronic Vascular, Santa Rosa, CA) was evaluated for magnetic field interactions, heating, and artifacts at 3 Tesla. MRI-related heating was assessed with the stent in a gelled saline-filled phantom using a transmit/received RF body coil with a whole body averaged SAR of 2.